Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT(1A) receptors: Reductions in neuroendocrine responses to 8- OH-DPAT and in levels of G(z) and G(i) proteins

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 98-106

  Raap, D K ^a   Evans, S ^a   Garcia, F ^a   Li, Q ^a   Muma, N A ^a   Wolf, W A ^a   Battaglia, G ^a   Van De Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FLUOXETINE; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOTHALAMUS; MALE; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BODY WEIGHT; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; GTP-BINDING PROTEINS; HORMONES; HYPOTHALAMUS; MALE; MEMBRANE PROTEINS; NEUROSECRETORY SYSTEMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032914750     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 1A antagonists. Trends Neurosci 19:378-383.
2. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73:277-280.
3. Barr AJ, Brass LF and Manning DR (1997) Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor-G protein coupling. J Biol Chem 272:2223-2229.
4. 1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system. Neuropsychopharmacology 15:213-214.
5. 1A receptors in the dorsal raphe and hippocampus: I effect of spiperone. J Pharmacol Exp Ther 265:7-17.
6. Boess FG and Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317.
7. Caccia S, Cappi M, Fracasso C and Garattini S (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509-514.
8. Clarke WP, De Vivo M, Beck SG, Maayani S and Goldfarb J (1987) Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate. Brain Res 410:357-361.
9. Connolly VM, Gallagher A and Kesson CM (1995) A study of fluoxetine in obese elderly patients with type 2 diabetes. Diabetic Medicine 12:416-418.
10. DeVane CL (1994) Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med 97: (Suppl. 6A):13S-23S.
11. Dryden S, Frankish HM, Wang Q, Pickavance L and Williams G (1996) The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 72:557-566.
12. Fuller RW, Snoddy HD, Perry KW, Bymaster FP and Wong DT (1978) Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-Comparison of fluoxetine and chlorimipramine. Biochem Pharmacol 27:193-198.
13. Fuller RW (1996) Mechanisms and functions of serotonin neuronal systems-Opportunities for neuropeptide interactions Ann NY Acad Sci 780:176-184.
14. Gardier AM, Le Poul E. Trouvin JH. Chanut E, Dessalles MC and Jacquot C (1994) Changes in dopamine metabolism in rat forebrain regions after cessation of longterm fluoxetine treatment: Relationship with brain concentrations of fluoxetine and norfluoxetine. Life Sci 54:PL51-PL56.
15. Goldberg RJ (1995) Diagnostic dilemmas presented by patients with anxiety and depression. Am J Med 98:278-284.
16. Greeno CG and Wing RR (1996) A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder. Am J Clin Nutr 64:267-273.
17. Halford JC and Blundell JE (1996) Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. Pharmacol Biochem Behav 54:745-751.
18. z is correlated with an inhibition of palmitoylation and membrane attachment, but has no effect on phosphorylation by protein kinase C. J Biol Chem 269:4571-4576.
19. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144.
20. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedeberg's Arch Pharmacol 352:141-148.
21. Lerer B, Gelfin Y and Gorfine M (1997) Temperature and hormone responses of normal subjects to ipsapirone challenge: Effect of fluoxetine treatment. Psychoneuroendocrinology 22:166.
22. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105:415-420.
23. Lesch KP and Manji HK (1992) Signal-transduction G proteins and antidepressant drugs: Evidence for modulation of α subunit gene expression in rat brain. Biol Psychiatry 32:549-579.
24. Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA and Van de Kar LD (1993a) Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCI (DOI). J Pharmacol Exp Ther 266:836-844.
25. 1A agonist 8-OH-DPAT in male rats. Brain Res 630:148-156.
26. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300-308.
27. 1A agonist. J Pharmacol Exp Ther 279:1035-1042.
28. 11 proteins. Brain Res 775:225-228.
29. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
30. o in neuroblastoma X glioma hybrid cells: independent regulation during cyclic AMP-induced differentiation. J Neurochem 55:1890-1898.
31. Nestler EJ, McMahon A, Sabban EL, Tallman JF and Duman RS (1990) Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci USA 87:7522-7526.
32. Nibuya M, Nestler EJ and Duman RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16:2365-2372.
33. Penington NJ, Kelly JS and Fox AP (1993) Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT1A receptors on dorsal raphe neurones of the adult rat. J Physiol (London) 469:387-405.
34. Quitkin FM, McGrath PJ, Stewart JW, Taylor BP and Klein DF (1996) Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15:390-394.
35. s alpha. Biochemistry 32:11064-11073
36. Rutter JJ, Gundlah C and Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171:183-186
37. 1A agonist 8-OH-DPAT Soc Neurosci Abst 24:539.18.
38. Steel RGD and Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences. New York: McGraw-Hill.
39. Trouvin JH, Gardier AM, Chanut E, Pages N and Jacquot C (1993) Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sci 52:PL187-PL192.
40. 1A receptor-mediated increase in oxytocin and ACTH secretion. Soc Neurosci Abstr 24:539.17.